Martin Enge

Martin Enge

Auto-generated profile, based on publicly available information

Martin Enge

Karolinska Institute

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SDSpyros Darmanis
Spyros Darmanis
SSSteven A. Sloan
Steven A. Sloan
YZYe Zhang
Ye Zhang
MEMartin Enge
Martin Enge
CCChristine Caneda
Christine Caneda
SQStephen Quake
Stephen Quake
Significance: The brain comprises an immense number of cells and cellular connections. We describe the first, to our knowledge, single cell whole transcriptome analysis of human adult cortical samples. We have established an experimental and analytical framework with which the complexity of the human brain can be dissected on the single cell level. Using this approach, we were able to identify all major cell types of the brain and characterize subtypes of neuronal cells. We observed changes in neurons from early developmental to late differentiated stages in the adult. We found a subset of adult neurons which express major histocompatibility complex class I genes and thus are not immune privileged.

1 January 2013 in Cell
Verified
Journal Article
Closed access
AJArttu Jolma
Arttu Jolma
JYJian Yan
Jian Yan
TWThomas Whitington
Thomas Whitington
JTJarkko Toivonen
Jarkko Toivonen
KNKazuhiro R. Nitta
Kazuhiro R. Nitta
JTJussi Taipale
Jussi Taipale

20 November 2011 in Nature Methods
Verified
Journal Article
Closed access
TKTeemu Kivioja
Teemu Kivioja
AVAnna Vähärautio
Anna Vähärautio
KKKasper Karlsson
Kasper Karlsson
MBMartin Bonke
Martin Bonke
MEMartin Enge
Martin Enge
JTJussi Taipale
Jussi Taipale

9 November 2015 in Nature
Verified
Journal Article
Closed access
AJArttu Jolma
Arttu Jolma
YYYimeng Yin
Yimeng Yin
KNKazuhiro R. Nitta
Kazuhiro R. Nitta
KDKashyap Dave
Kashyap Dave
APAlexander Popov
Alexander Popov
JTJussi Taipale
Jussi Taipale

21 November 2004 in Nature Medicine
Verified
Journal Article
Open access
PDF file
Natalia IssaevaNatalia Issaeva
Natalia Issaeva
PBPrzemyslaw Bozko
Przemyslaw Bozko
MEMartin Enge
Martin Enge
MPMarina Protopopova
Marina Protopopova
LVLisette G G C Verhoef
Lisette G G C Verhoef
GSGalina Selivanova
Galina Selivanova
In tumors that retain wild-type p53, its tumor-suppressor function is often impaired as a result of the deregulation of HDM-2, which binds to p53 and targets it for proteasomal degradation. We have screened a chemical library and identified a small molecule named RITA (reactivation of p53 and induction of tumor cell apoptosis), which bound to p53 and induced its accumulation in tumor cells. RITA prevented p53–HDM-2 interaction in vitro and in vivo and affected p53 interaction with several negative regulators. RITA induced expression of p53 target genes and massive apoptosis in various tumor cells lines expressing wild-type p53. RITA suppressed the growth of human fibroblasts and lymphoblasts only upon oncogene expression and showed substantial p53-dependent antitumor effect in vivo. RITA may serve as a lead compound for the development of an anticancer drug that targets tumors with wild-type p53.

14 October 2011 in Science
Verified
Journal Article
Closed access
PDF file
NMNetta Mäkinen
Netta Mäkinen
MMMiika Mehine
Miika Mehine
JTJaana Tolvanen
Jaana Tolvanen
EKEevi Kaasinen
Eevi Kaasinen
YLYilong Li
Yilong Li
LALauri A. Aaltonen
Lauri A. Aaltonen
Uterine leiomyomas, or fibroids, are benign tumors that affect millions of women worldwide and that can cause considerable morbidity. To study the genetic basis of this tumor type, we examined 18 uterine leiomyomas derived from 17 different patients by exome sequencing and identified tumor-specific mutations in the mediator complex subunit 12 (MED12) gene in 10. Through analysis of 207 additional tumors, we determined that MED12 is altered in 70% (159 of 225) of tumors from a total of 80 patients. The Mediator complex is a 26-subunit transcriptional regulator that bridges DNA regulatory sequences to the RNA polymerase II initiation complex. All mutations resided in exon 2, suggesting that aberrant function of this region of MED12 contributes to tumorigenesis.